SOLX, Inc.: Clinical Trials

3 trials sponsored by SOLX, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 suspended. 2 Phase 3, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Suspended 1
Not applicable1Completed 1

Follow SOLX, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SOLX Gold Shunt for Refractory Glaucoma
SOLX Gold Shunt - Glaucoma, Glaucoma, Open Angle
Not applicableCompletedSOLX, Inc.1162011-01-012017-02-23
SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma
SOLX Gold Shunt GMS-plus, Ahmed FP7 Glaucoma Valve - Glaucoma, Glaucoma, Open Angle
Phase 3SuspendedSOLX, Inc.1802005-11-012015-09-18
SOLX Titanium Sapphire Laser for Trabeculoplasty
SOLX Titanium Sapphire Laser (TiSaLT), Argon Laser Trabeculoplasty (ALT) - Glaucoma, Glaucoma, Open Angle
Phase 3CompletedSOLX, Inc.1202004-05-012010-01-29

Conditions studied

Glaucoma (3)  ·  Glaucoma, Open-Angle (3)

Countries

Canada (3)  ·  Israel (3)  ·  United States (3)  ·  Brazil (1)  ·  India (1)  ·  Poland (1)  ·  Spain (1)  ·  Venezuela (1)

Top investigators

Jan S Peterson, MS, RAC (1)  ·  Jan S. Peterson, MS, RAC (1)  ·  Nilay Shah, MD (1)